SCHEMBL5720657

SCHEMBL5720657

CCC(N)(O)c1nc(N2CCOCC2)c2nc(Nc3cccc(C)c3)[nH]c2n1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.45
TP53 P04637 2/20 0.45
POLB P06746 1/20 0.45
CHEK1 O14757 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
GBA1 P04062 1/20 0.42
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
PIK3CD O00329 2/20 0.40
PIK3CB P42338 2/20 0.40
AKT1 P31749 1/20 0.40
PIK3CA P42336 1/20 0.40
PIK3CG P48736 1/20 0.40
SRC P12931 1/20 0.40
CA12 O43570 1/20 0.40
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA9 Q16790 1/20 0.40
RAB9A P51151 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720652 0.89 MAPT (0.45) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL425747 0.82 MAPT (0.52) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL3326864 0.81 MAPT (0.61) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL3326035 0.80 MAPT (0.52) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL427561 0.80 GBA1 (0.49) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL5720646 0.79 CHEK1 (0.48) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL430842 0.79 GBA1 (0.65) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL426750 0.78 CHEK1 (0.55) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL3325223 0.78 SLC29A1 (0.52) MAPTTP53POLBCHEK1ALDH1A1
SCHEMBL10198825 0.78 CHEK1 (0.50) MAPTTP53POLBCHEK1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1626725-A2 HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS Synta Pharmaceuticals Corporation (US) 2006-02-22 EP disclosed
WO-2005000404-A2 HETEROCYCLIC COMPOUNDS FOR PREVENTING AND TREATING DISORDERS ASSOCIATED WITH EXCESSIVE BONE LOSS SYNTA PHARMACEUTICALS, CORP. (US) 2005-01-06 WO disclosed